Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder

NCT02893111 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica Spectrum Disorder

Interventions

DRUG: Bortezomib

Sponsor

Tianjin Medical University General Hospital